UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Genexine’s new immunotherapy shows stability even in high dose
GX-I7, a new immunotherapy candidate being developed jointly by Genexine an...
by Jeong Sae-im
|
2019-11-11 13:36
라인
Medpacto releases trial results at US conference
Medpacto, a subsidiary of Theregen ETEX, said Monday that it has presented ...
by Lee Han-soo
|
2019-11-11 13:27
라인
Doctors should take lead in use of medical AI
Amid the mounting interests in and the use of artificial intelligence and b...
by Choi Gwang-seok
|
2019-11-08 20:27
라인
[Column] Korea should do better in diabetes management
Each year, November 14 is marked as World Diabetes Day, designated by the U...
by Park Tae-sun
|
2019-11-08 15:57
라인
KDA, KBR team up for global promotion of Korean medicine
Korean Diabetes Association (KDA), Korea’s first healthcare-focused English...
by Lee Hye-seon
|
2019-11-08 14:09
라인
‘Cancer patients suffered side effects after taking anthelmintic drug’
Some cancer patients took a deworming medicine to cure their disease but su...
by Jeong Sae-im
|
2019-11-08 13:30
라인
Yuhan, Cyclica to co-develop new drugs
Yuhan Corp. said that it would develop a new drug with Cyclica, a Canadian ...
by Lee Han-soo
|
2019-11-07 18:01
라인
KIST-Dongguk researchers use composite images to track stem cell growth
Stem cells have long received significant attention recently because of the...
by Lee Han-soo
|
2019-11-07 16:27
라인
Takeda’s labor turmoil goes to extremes amid rumored unit sell-off
Takeda Pharmaceutical Korea’s conflict between labor and management is risi...
by Kim Yun-mi
|
2019-11-07 16:10
라인
AMC confirms efficacy of radiofrequency ablation therapy on thyroid cancer
A research team at Asan Medical Center has confirmed, through an extended f...
by Lee Han-soo
|
2019-11-07 15:20
라인
Seniors account for 41% of total medical expense
The nation’s total medical cost covered by national health insurance went u...
by Kim Eun-young
|
2019-11-07 15:16
라인
8 Chinese medical schools delisted from world directory of medical schools
Eight Chinese medical schools have been delisted from the World Directory o...
by Choi Gwang-seok
|
2019-11-07 14:07
라인
‘Lung cancer screening was effective in numerous studies’
Since the government started lung cancer screening in July, some experts ha...
by Jeong Sae-im
|
2019-11-07 14:06
라인
Celltrion marks robust Q3 sales
Celltrion said that it has recorded sales of 289.1 billion won ($249 millio...
by Lee Han-soo
|
2019-11-07 14:03
라인
Samsung Bioepis, Biogen to commercialize next-generation biosimilar candidates
Samsung Bioepis said the company would strengthen its partnership with Biog...
by Lee Han-soo
|
2019-11-07 11:16
라인
'AI accurately diagnoses abnormalities from chest X-rays'
Researchers at Seoul National University Hospital have confirmed that artif...
by Lee Han-soo
|
2019-11-07 08:25
라인
‘One-third of heart attack survivors overlook risk of recurrence’
Amgen Korea has released findings from a survey on Korean heart attack surv...
by Lee Han-soo
|
2019-11-06 16:34
라인
AbbVie’s hepatitis C drug gets 8-week therapy regardless of cirrhosis
AbbVie said it has obtained regulatory approval for an eight-week treatment...
by Kim Yun-mi
|
2019-11-06 16:00
라인
Crystal Genomics, Daehwa win patent for patch-form arthritis drug
Crystal Genomics and Daehwa Pharmaceutical said they have registered a pate...
by Lee Han-soo
|
2019-11-06 15:57
라인
Shorter residency in internal medicine causes treatment vacuum
As hospitals shortened internal medicine residency training from four to th...
by Choi Gwang-seok
|
2019-11-06 15:56
-
이전
81
82
83
84
85
86
87
88
89
90
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top